Mark Kaminski

University of Michigan–Ann Arbor — United States

Medicine · Health Sciences

58h-index14.8kcitations355works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(169), Chronic Lymphocytic Leukemia Research(90), Monoclonal and Polyclonal Antibodies Research(61), Radiopharmaceutical Chemistry and Applications(56), Lung Cancer Treatments and Mutations(43)

Publications354 total

Outcomes of Sequenced Therapy in Mantle Cell Lymphoma in Patients Treated with First-Line Autologous Stem Cell Transplantation and Second-Line BTK Inhibitor
Blood·2024
Assessment of Tumor Metabolic Volume (TMV) As a Predictor of Outcomes in Patients with Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma (PMBCL)
Blood·2024
Incidence, Characteristics and Outcomes in Relapsed and Refractory CD20+ PTLD: An Institutional Retrospective Cohort Study
Clinical Lymphoma Myeloma & Leukemia·2024
ABCL-616 Incidence, Characteristics and Outcomes in Relapsed and Refractory CD20+ PTLD: An Institutional Retrospective Cohort Study
Clinical Lymphoma Myeloma & Leukemia·2024
Incidence, characteristics and outcomes in relapsed and refractory CD20+ PTLD: An institutional retrospective cohort study.
Journal of Clinical Oncology·2024· 1 cited
Outcomes and prognostic factors of patients diagnosed with relapsed/refractory primary B-cell lymphoma: A retrospective study.
Journal of Clinical Oncology·2024· 1 cited
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023
Journal of the National Comprehensive Cancer Network·2023· 102 citedOpen Access
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
Blood Advances·2023· 11 citedOpen Access
A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016
Hematological Oncology·2023· 2 citedOpen Access
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
Blood Advances·2023· 17 citedOpen Access
Supplementary Data Table S1 from Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
2023Open Access
Data from Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
2023Open Access
Data from Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma
2023Open Access
Supplementary Data from Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
2023Open Access
Supplementary Figure 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + <sup>131</sup>Iodine—Tositumomab
2023Open Access
Data from A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figures 1-12 and Tables S1-S2 from Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
2023Open Access
Supplementary Data Table S1 from Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
2023Open Access
Supplementary Figure 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + <sup>131</sup>Iodine—Tositumomab
2023Open Access
Supplementary Data from Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
2023Open Access
page 1 of 18Next →

Frequent Co-authors

Andrew D. Zelenetz(14), Richard L. Wahl(14), Leo I. Gordon(13), Ranjana H. Advani(13), Julie M. Vose(10), Ann S. LaCasce(8), Kenneth Zasadny(8), Isaac R. Francis(8), Rachel Rabinovitch(8), Nancy L. Bartlett(7), Oliver W. Press(7), Jeremy S. Abramson(7), Francisco J. Hernandez‐Ilizaliturri(7), Hema Sundar(7), Denise Regan(6), Stewart Kroll(6), Steven M. Horwitz(6), John P. Leonard(6), Martha Glenn(6), Joachim Yahalom(6)